CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomasJoseph Flores‐Toro, Jeffrey K. Harrison, Adithya Gopinath et al.|Proceedings of the National Academy of Sciences|2019Cited by 330
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant mannerGregory P. Takacs, Jeffrey K. Harrison|Frontiers in Immunology|2023Cited by 66